HIV-1 and HCV infections among antibody-negative blood donors [1] (multiple letters)

New England Journal of Medicine

Volumn 351, Issue 21, 2004, Pages 2232-2235

  Begovac, Josip ^a   Mihaljevic, Ivanka ^b   Perrin, Luc ^c   Laperche, Syria ^d   Pillonel, Josiane ^e   Herve, Patrick ^f   Prince, Alfred M ^g   Kainer, Marion A ^h   Jarvis, William R ⁱ   Stramer, Susan L ^j   Dodd, Roger Y ^j   Busch, Michael P ^k   Goodman, Jesse L ^l  

^a Croatia   (Croatia)

^b CROATIAN INSTITUTE OF TRANSFUSION MEDICINE   (Croatia)

^c GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^d INSTITUT NATIONAL DE LA TRANSFUSION SANGUINE   (France)

^e INSTITUT DE VEILLE SANITAIRE   (France)

^f ETABLISSEMENT FRANÇAIS DU SANG   (France)

^g NEW YORK BLOOD CENTER   (United States)

^h TENNESSEE DEPARTMENT OF HEALTH   (United States)

ⁱ American Red Cross ^*  (United States)

^j AMERICAN RED CROSS   (United States)

^k BLOOD SYSTEMS RESEARCH INSTITUTE   (United States)

^l CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; HEPATITIS C ANTIBODY; HUMAN IMMUNODEFICIENCY VIRUS 1 ANTIBODY; HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY; PROTEINASE; REAGENT; RNA DIRECTED DNA POLYMERASE; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; BLOOD DONOR; BLOOD SAMPLING; CLOSTRIDIUM; COST EFFECTIVENESS ANALYSIS; FOOD AND DRUG ADMINISTRATION; HEPATITIS B VIRUS; HEPATITIS C; HEPATITIS C VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCIDENCE; LETTER; NONHUMAN; NUCLEIC ACID AMPLIFICATION; PLASMA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RISK; SCREENING; SEROCONVERSION; SEROPREVALENCE; THROMBOCYTE; VIRUS TRANSMISSION; BLOODBORNE BACTERIUM; COST BENEFIT ANALYSIS; DISEASE TRANSMISSION; DONOR; EPIDEMIOLOGY; HEALTH CARE FACILITY; HUMAN; INFORMED CONSENT; ISOLATION AND PURIFICATION; NOTE; STANDARD; VIRUS INFECTION; BLOOD; FRANCE; COST; ECONOMICS; WEST NILE FLAVIVIRUS; HUMAN IMMUNODEFICIENCY VIRUS 2; LABORATORY DIAGNOSIS;

BLOOD DONORS; BLOOD-BORNE PATHOGENS; COST-BENEFIT ANALYSIS; HUMANS; INFORMED CONSENT; SEROEPIDEMIOLOGIC STUDIES; TISSUE BANKS; TISSUE DONORS; VIRUS DISEASES; FRANCE; HEPACIVIRUS; HEPATITIS C; HEPATITIS C ANTIBODIES; HIV ANTIBODIES; HIV INFECTIONS; HIV-1; NUCLEIC ACID AMPLIFICATION TECHNIQUES; COSTS AND COST ANALYSIS; HEPATITIS B VIRUS; POLYMERASE CHAIN REACTION; WEST NILE VIRUS; DISEASE TRANSMISSION, HORIZONTAL; FALSE NEGATIVE REACTIONS; HIV-2;

EID: 8644237435     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJM200411183512117     Document Type: Letter

References (0)